LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Radiopharmaceuticals Oncoinvent focuses on developing cutting-edge alpha-emitting radiopharmaceutical products for cancer treatment, presenting opportunities to collaborate on advanced manufacturing, radiolabelling, and clinical trial support for novel therapies.

Strategic Partnerships The company's recent partnership with ARTBIO and its merger with BerGenBio indicate a willingness to expand through collaborations, offering potential sales channels in radiolab facilities, regulatory expertise, and pharmaceutical distribution.

Expanding Leadership With recent appointments of a new CFO and CEO, Oncoinvent is actively strengthening its management team, creating openings for enterprise service providers in finance, strategic planning, and operational consulting to support its growth.

Market Potential Operating in the biotech sector with a focus on radiotherapy for cancers, Oncoinvent’s niche positions it for opportunities to supply research reagents, laboratory equipment, and regulatory compliance services tailored to radiopharmaceutical development.

Funding and Growth With an active funding portfolio and a revenue range of up to 10 million dollars, there are prospects to offer financial advisory, grant support, and investment facilitation services to accelerate their research and commercialization efforts.

Similar companies to Oncoinvent ASA

Oncoinvent ASA Tech Stack

Oncoinvent ASA uses 8 technology products and services including MySQL, oEmbed, Shopify, and more. Explore Oncoinvent ASA's tech stack below.

  • MySQL
    Database
  • oEmbed
    Dev Tools
  • Shopify
    E-commerce
  • jQuery
    Javascript Libraries
  • Elementor
    Page Builders
  • Priority Hints
    Performance
  • reCAPTCHA
    Security
  • Bootstrap
    UI Frameworks

Media & News

Oncoinvent ASA's Email Address Formats

Oncoinvent ASA uses at least 1 format(s):
Oncoinvent ASA Email FormatsExamplePercentage
Last@oncoinvent.comDoe@oncoinvent.com
46%
First.Last@oncoinvent.comJohn.Doe@oncoinvent.com
37%
First.Middle.Last@oncoinvent.comJohn.Michael.Doe@oncoinvent.com
16%
FirstL@oncoinvent.comJohnD@oncoinvent.com
1%

Frequently Asked Questions

Where is Oncoinvent ASA's headquarters located?

Minus sign iconPlus sign iconOncoinvent ASA's main headquarters is located at Gullhaugveien 7, Oslo, Oslo 0484, NO. The company has employees across 2 continents, including EuropeNorth America.

What is Oncoinvent ASA's phone number?

Minus sign iconPlus sign icon You can contact Oncoinvent ASA's main corporate office by phone at
+47-22-18-3****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Oncoinvent ASA's official website and social media links?

Minus sign iconPlus sign iconOncoinvent ASA's official website is oncoinvent.com and has social profiles on LinkedInCrunchbase.

What is Oncoinvent ASA's SIC code NAICS code?

Minus sign iconPlus sign iconOncoinvent ASA's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Oncoinvent ASA have currently?

Minus sign iconPlus sign iconAs of October 2025, Oncoinvent ASA has approximately 45 employees across 2 continents, including EuropeNorth America. Key team members include Chief Executive Officer: O. S.Chief Operating Officer: G. E. H.Chief Production Officer: K. L.. Explore Oncoinvent ASA's employee directory with LeadIQ.

What industry does Oncoinvent ASA belong to?

Minus sign iconPlus sign iconOncoinvent ASA operates in the Biotechnology Research industry.

What technology does Oncoinvent ASA use?

Minus sign iconPlus sign iconOncoinvent ASA's tech stack includes MySQLoEmbedShopifyjQueryElementorPriority HintsreCAPTCHABootstrap.

What is Oncoinvent ASA's email format?

Minus sign iconPlus sign iconOncoinvent ASA's email format typically follows the pattern of Last@oncoinvent.com. Find more Oncoinvent ASA email formats with LeadIQ.

How much funding has Oncoinvent ASA raised to date?

Minus sign iconPlus sign icon As of October 2025, Oncoinvent ASA has raised $12M in funding. The last funding round occurred on Dec 04, 2024 for $12M.

When was Oncoinvent ASA founded?

Minus sign iconPlus sign iconOncoinvent ASA was founded in 2010.

Oncoinvent ASA

Biotechnology ResearchNorway11-50 Employees

Oncoinvent is a clinical stage company committed to developing new innovative radiopharmaceutical products for better treatment options for cancer patients.

Radspherin®, the company’s lead product candidate is a novel alpha-emitting radioactive microsphere suspension designed for treatment of metastatic cancers in body cavities. Radspherin® has shown strong and consistent anticancer activity at essentially non-toxic doses in preclinical studies and is anticipated to potentially treat several forms of metastatic cancer.

Situated in Oslo, Oncoinvent’s main offices include modern laboratory facilities suitable for cGMP and radiopharmaceutical manufacture for clinical trials and research. The development programs of the company include radiotherapeutic and radioimmunotherapeutic products with focus on alpha-emitting radionuclides for treatment of various solid cancers.

Section iconCompany Overview

Headquarters
Gullhaugveien 7, Oslo, Oslo 0484, NO
Phone number
+47-22-18-3****
Website
oncoinvent.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2010
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $12M

    Oncoinvent ASA has raised a total of $12M of funding over 4 rounds. Their latest funding round was raised on Dec 04, 2024 in the amount of $12M.

  • $1M$10M

    Oncoinvent ASA's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $12M

    Oncoinvent ASA has raised a total of $12M of funding over 4 rounds. Their latest funding round was raised on Dec 04, 2024 in the amount of $12M.

  • $1M$10M

    Oncoinvent ASA's revenue is estimated to be in the range of $1M$10M

Company Leadership

  • Stylized image of a person
    O. S.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    G. E. H.
    Chief Operating Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. L.
    Chief Production Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    I. E.
    Head Of Quality Control
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. T. J.
    Head Of Quality Control
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    K. T. J.
    Head Of Quality Control
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. B.
    Head Of Regulatory Affairs
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. C. A.
    Head Of Qa/Qp
    Phone icon
    Mobile Phone
  • Stylized image of a person
    R. T.
    Senior Financial Controller
    Phone icon
    Mobile Phone
  • Stylized image of a person
    H. M. H.
    Pharmaceutical Manufacturing Director
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.